Cart
sales@molnova.com
Obovatol
CAS No. 83864-78-2
Obovatol( —— )
Catalog No. M29648 CAS No. 83864-78-2
Obovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 256 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameObovatol
-
NoteResearch use only, not for human use.
-
Brief DescriptionObovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb.
-
DescriptionObovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number83864-78-2
-
Formula Weight282.33
-
Molecular FormulaC18H18O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 200 mg/mL (708.39 mM; Need ultrasonic)
-
SMILESOC1=CC(CC=C)=CC(OC2=CC=C(CC=C)C=C2)=C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ito K, et al. Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem Pharm Bull (Tokyo). 1982;30(9):3347-3353.
molnova catalog
related products
-
Thalidomide-NH-PEG1-...
Thalidomide-NH-PEG1-NH2 hydrochloride is a synthetic E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker.
-
trans-4-(Trifluorome...
trans-4-(Trifluoromethyl)cinnamic acid is a photosensitizing compound. It is used as a reagent in the synthesis of various compounds, such as heterocyclic compounds and pharmaceuticals.
-
ShK-Dap22
Extremely potent KV1.3 channel blocker (Kd = 23 pM for mKV1.3 currents). Selective for KV1.3 over other mammalian potassium channels (IC50 values are 23, 1800, 10500, 37000 and 39000 pM for mKV1.3, mKV1.1, hKV1.6, mKV1.4 and rKV1.2 respectively, and >100000 pM for hKV1.5, mKV1.7, hKV3.1, rKV3.4 and hKCa4). Suppresses T cell activation in vitro (IC50 < 500 pM).
